Phenotype-based Model for Managing Chronic Post-treatment Pain Among Head and Neck Cancer Survivors: a Pilot Study
The goal of this clinical trial is to find out whether a phenotype-based pain management approach can reduce chronic pain in adults (18 years and older) who have completed curative treatment for head and neck cancer and continue to experience chronic post-treatment pain.
The main questions it aims to answer are:
* Does a phenotype-based pain management approach reduce participants' average pain by at least 75% after one month of treatment?
* Is the treatment safe, with 10% or fewer participants stopping treatment because of side effects?
Participants will:
* Attend three study visits over one month (at baseline, 2 weeks, and 4 weeks).
* Complete questionnaires about their pain, anxiety, depression, medication side effects, and use of pain medicines.
* Undergo a detailed examination to identify the type (phenotype) of their pain.
* Receive a treatment plan tailored to their pain phenotype, which may include medications, trigger point injections, or nerve blocks, depending on their symptoms and pain severity.
* Return for follow-up visits to assess pain relief, medication side effects, and use of breakthrough pain medication.
Gender: All
Ages: 18 Years - Any
Chronic Postsurgical Pain
Chronic Post Cancer Surgery Pain
Chronic Post Operative Pain
+2